Vanguard Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.93B | Sell |
|
|||||
2025
Q1 | $5.44B | Sell |
|
|||||
2024
Q4 | $4.75B | Sell |
|
|||||
2024
Q3 | $6.51B | Sell |
|
|||||
2024
Q2 | $5.41B | Sell |
|
|||||
2024
Q1 | $5.67B | Buy |
|
|||||
2023
Q4 | $4.58B | Sell |
|
|||||
2023
Q3 | $4.21B | Sell |
|
|||||
2023
Q2 | $5.31B | Sell |
|
|||||
2023
Q1 | $4.72B | Sell |
|
|||||
2022
Q4 | $4.31B | Sell |
|
|||||
2022
Q3 | $3.32B | Sell |
|
|||||
2022
Q2 | $3.13B | Sell |
|
|||||
2022
Q1 | $4.79B | Buy |
|
|||||
2021
Q4 | $4.86B | Sell |
|
|||||
2021
Q3 | $4.85B | Sell |
|
|||||
2021
Q2 | $4.34B | Sell |
|
|||||
2021
Q1 | $3.96B | Buy |
|
|||||
2020
Q4 | $3.42B | Sell |
|
|||||
2020
Q3 | $2.6B | Sell |
|
|||||
2020
Q2 | $2.04B | Sell |
|
|||||
2020
Q1 | $1.92B | Buy |
|
|||||
2019
Q4 | $3.1B | Buy |
|
|||||
2019
Q3 | $2.52B | Buy |
|
|||||
2019
Q2 | $2.82B | Buy |
|
|||||
2019
Q1 | $2.71B | Buy |
|
|||||
2018
Q4 | $2.56B | Buy |
|
|||||
2018
Q3 | $2.77B | Buy |
|
|||||
2018
Q2 | $2.04B | Buy |
|
|||||
2018
Q1 | $1.88B | Buy |
|
|||||
2017
Q4 | $1.7B | Sell |
|
|||||
2017
Q3 | $1.57B | Sell |
|
|||||
2017
Q2 | $1.72B | Buy |
|
|||||
2017
Q1 | $1.74B | Buy |
|
|||||
2016
Q4 | $1.42B | Sell |
|
|||||
2016
Q3 | $1.48B | Sell |
|
|||||
2016
Q2 | $1.51B | Sell |
|
|||||
2016
Q1 | $1.53B | Buy |
|
|||||
2015
Q4 | $1.26B | Buy |
|
|||||
2015
Q3 | $1.43B | Buy |
|
|||||
2015
Q2 | $1.54B | Buy |
|
|||||
2015
Q1 | $1.26B | Buy |
|
|||||
2014
Q4 | $883M | Buy |
|
|||||
2014
Q3 | $818M | Buy |
|
|||||
2014
Q2 | $645M | Buy |
|
|||||
2014
Q1 | $576M | Buy |
|
|||||
2013
Q4 | $509M | Buy |
|
|||||
2013
Q3 | $379M | Buy |
|
|||||
2013
Q2 | $307M | Buy |
|